지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
Objectives : The aims of this study were to discriminate the clinical differences, to measure the estrogen and homovanillic acid levels, to evaluate a correlation between estrogen and homovanillic acid, and to identify an association of cognitive deficit with estrogen and homovanillic acid among male and female schizophrenics. Methods : In addition to the structured interviews, the plasma estrogen levels by radioimmunoassay and the homovanillic acid levels by HPLC were measured in 20 male and 21 female schizophrenics as well as 10 healthy male and 9 female controls. Results : 1) The plasma estrogen levels were higher in females than males, and significantly higher in female schizophenics than female controls. The homovanillic acid levels were higher in female schizophrenics than female controls, and were lower in male schizophrenics than male controls. 2) The onset age seemed to be earlier in male schizophrenics, and the frequency of admission, duration of antipsychotic drug administration, dosage of antipsychotics and duration of illnesses were more in males. The estrogen and homovanillic acid levels were significantly higher in female schizophrenics. 3) The estrogen levels had a significant positive correlation with sex, age and onset age, while the homovanillic acid levels did with sex. However, estrogen were not correlated with homovanillic acid levels. 4) The estrogen and homovanillic acid levels were not significantly different between male and female schizophrenics with cognitive deficits. In the schizophrenic patients without cognitive deficits, the estrogen levels were significantly higher in females, while there were no significant sex differences in homovanillic acid. 5) In the male and female schizophrenics predominantly with negative symptoms, there were no significant differences in estrogen and homovanillic acid levels. In those predominantly with positive symptoms, the estrogen levels were significantly higher in females, while there were no sex differences in homovanillic acid levels. 6) In schizophrenics with undifferentiated subtype, the estrogen and homovanillic acid levels were significantly higher in females. In those with paranoid or disorganized subtypes, the estrogen levels were significantly higher in females, while there were no sex differences in the homovanillic acid levels. 7) The mean values of PANSS-negative, PANSS-total, PANSS-CF, MMSE-K and estrogen levels were significantly higher in male schizophrenics with cognitive deficits. The mean values of illness duration, CGI, PANSS-positive, PANSS-negative, PANSS-total, PANSS-CF and MMSE-K were significantly higher in female schizophrenics with cognitive deficits. 8) The variables which showed significant correlation with cognitive deficits were PANSS-negative, PANSS-total, PANSS-CF, MMSE-K and estrogen levels in male schizophrenics. The variables which showed significant correlation with cognitive deficits were subtypes, onset age, illness durataion, CGI, PANSS-positive, PANSS-negative, PANSS-total, PANMSS-CF and MMSE-K in female schizophrenics. The estrogen levels were significantly correlated with admission frequencies, history of antipsychotic administration, duration of antipsychotic administration and cognitive deficits in male schizophrenics, while age were not correlated with in females. The homovanillic acid levels had a significant correlation with subtypes and onset age in male schizophrenics, while there were no correlation among variables in females. Conclusions : Although the plasma concentrations of estrogen and homovanillic acid in female schizophrenics were significantly higher than males, we could not find an association between them. Furthermore, the various factors affecting on the cognitive deficits, estrogen and homovanillic acid levels seemed to be somewhat different according to sex.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
만성 여성 정신분열병 환자에서 Estrogen 병합투여의 임상시도
생물정신의학
1998 .01
-
여자 정신분열병 환자에서 혈중 에스트로겐 농도와 추체외로 증상과의 관계
생물정신의학
2001 .01
-
Estrogen Receptor 1 유전자 내 2개의 단일염기 다형성과 한국인 여성 정신분열병 환자의 연합에 관한 연구
생물정신의학
2007 .01
-
Estrogen in Female Reproductive Axis;Positive Estrogen Feedback to Pituitary
대한생식의학회 학술대회
2007 .01
-
Estrogen in Female Reproductive Axis: Positive Estrogen Feedback to Pituitary
대한생식의학회지
2007 .01
-
Estrogen Modulation of Human Breast Cancer Cell Growth
Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea
1997 .01
-
Action mechanism of Antiestrogenicity of Ginkgo biloba extracts and its major components in human breast cancer cell
대한약학회 학술대회
2003 .01
-
유방암종괴의 Estrogen 수용체에 대한 임상적 고찰
Annals of Surgical Treatment and Research
1990 .06
-
만성 정신분열병 환자에서 도파민 D3 수용체 다형성 및 혈장 Homovanillic Acid와 5-hydroxyindoleacetic Acid 농도의 치료반응과의 연관
생물정신의학
2001 .01
-
정신분열병(精祥分裂病) 환자(患者)의 사회적(社會的) 지지망(支持網) 분석(分析)
정신신체의학
1996 .01
-
정신분열병환자의 발병연령과 항정신병약물 투여전후의 혈장 Homovanillic acid, 3-methoxy-4-hydroxyphenylglycol농도의 연관성
신경정신의학
2003 .01
-
난소적출술 환자에서 Estrogen 단독요법 및 Estrogen-androgen 병합요법에 관한 연구
대한불임학회지
2002 .01
-
만발성 여성 정신분열병 환자에서 폐경 전 발병군과 폐경 후 발병군의 임상적 특징 비교
생물치료정신의학
2007 .12
-
Functions and physiological roles of two types of estrogen receptors, ERα and ERβ, identified by estrogen receptor knockout mouse
Laboratory Animal Research
2012 .06
-
성별에 따른 조현병 환자의 공감 능력 및 얼굴 정서 인식 능력의 차이
생물정신의학
2014 .01
-
정신 분열증 환자에서 Fluoxetine 투여에 따른 양성증상, 음성 증상 및 우울 증상의 변화
생물정신의학
1996 .01
-
Synthesis of homovanillic amide derivatives and their analgesic activity
Archives of pharmacal research : a publication of the Pharmaceutical Society of Korea
1996 .01
-
정신분열증 환자에서 혈장 HVA 및 5-HIAA 농도와 정신병리와의 상관성
생물정신의학
1997 .01
-
정신분열병 환자의 기억기능
신경정신의학
2004 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0